skip to content


BTG's PneumRx Coils included in new guidelines

05 December 2016 07:58

BTG has announced the inclusion of treatment with PneumRx Coils in guidelines for the management of chronic obstructive pulmonary disease (COPD) published by the Global Initiative for Chronic Obstructive Lung Disease.

At the same time, the French Ministry of Health has published its positive recommendations regarding PneumRx Coils on its website. The updated GOLD guidelines now include endobronchial coils as a minimally invasive, bronchoscopic approach to reducing hyperinflation in severe emphysema patients.

This update includes coils as a therapy option for emphysema predominant patients with severe hyperinflation, regardless of disease distribution or presence of collateral ventilation. The French Ministry of Health published its positive recommendations regarding PneumRx Coils on its website as meeting an unmet medical need and fulfilling a public health interest based on therapeutic improvement over optimal medical therapy. This assessment will be a critical component in determining national reimbursement for treatment of patients with severe emphysema in France.

Both the GOLD recommendations and determination by the French Ministry of Health are based on two multicenter randomized controlled trials that examined the use of PneumRx Coils compared to usual care in changes in quality of life, lung function and exercise capacity in patients with advanced homogeneous and heterogeneous emphysema. BTG chief medical officer Guenter R. Janhofer said: "We're pleased that both GOLD and the French Ministry of Health have acknowledged the value of PneumRx Coils for emphysema patients. In both randomised, controlled, multi-centre studies, patients treated with the PneumRx Coil experienced improvements in quality of life, lung function, and exercise capacity. Data and imaging analysis is ongoing to further consider best practices for patient selection. This analysis will be shared in upcoming publications to provide additional treatment considerations to physicians."

Story provided by

Related Company: BTG

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?


Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.